163 related articles for article (PubMed ID: 6583439)
1. Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience.
Curtis RE; Hankey BF; Myers MH; Young JL
J Natl Cancer Inst; 1984 Mar; 72(3):531-44. PubMed ID: 6583439
[TBL] [Abstract][Full Text] [Related]
2. Leukemia following chemotherapy for breast cancer.
Curtis RE; Boice JD; Moloney WC; Ries LG; Flannery JT
Cancer Res; 1990 May; 50(9):2741-6. PubMed ID: 2328500
[TBL] [Abstract][Full Text] [Related]
3. Leukemia after therapy with alkylating agents for childhood cancer.
Tucker MA; Meadows AT; Boice JD; Stovall M; Oberlin O; Stone BJ; Birch J; Voûte PA; Hoover RN; Fraumeni JF
J Natl Cancer Inst; 1987 Mar; 78(3):459-64. PubMed ID: 3469460
[TBL] [Abstract][Full Text] [Related]
4. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
5. Acute leukemia occurring in a primary neoplasia (secondary leukemia). A Review of biological, epidemiological and clinical aspects.
Brusamolino E; Pagnucco G; Bernasconi C
Haematologica; 1986; 71(1):60-83. PubMed ID: 3084360
[No Abstract] [Full Text] [Related]
6. Leukemia in women following radiotherapy for cervical cancer: ten-year follow-up of an international study.
Boice JD; Hutchison GB
J Natl Cancer Inst; 1980 Jul; 65(1):115-29. PubMed ID: 6993742
[TBL] [Abstract][Full Text] [Related]
7. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
Glanzmann C; Veraguth A; Lütolf UM
Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
[TBL] [Abstract][Full Text] [Related]
8. Acute leukemia after alkylating-agent therapy of ovarian cancer.
Reimer RR; Hoover R; Fraumeni JF; Young RC
N Engl J Med; 1977 Jul; 297(4):177-81. PubMed ID: 406560
[TBL] [Abstract][Full Text] [Related]
9. Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma.
Wright JD; St Clair CM; Deutsch I; Burke WM; Gorrochurn P; Sun X; Herzog TJ
Cancer; 2010 May; 116(10):2486-92. PubMed ID: 20209618
[TBL] [Abstract][Full Text] [Related]
10. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
[TBL] [Abstract][Full Text] [Related]
11. Study of erythrocyte mean corpuscular volume during cytotoxic therapy as a predictive parameter of the risk of secondary leukemia in Hodgkin's disease.
de Gramont A; Rioux E; Drolet Y; Delage JM
Cancer Treat Rep; 1984 Dec; 68(12):1467-70. PubMed ID: 6509452
[TBL] [Abstract][Full Text] [Related]
12. Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease.
Inskip PD; Kleinerman RA; Stovall M; Cookfair DL; Hadjimichael O; Moloney WC; Monson RR; Thompson WD; Wactawski-Wende J; Wagoner JK
Radiat Res; 1993 Jul; 135(1):108-24. PubMed ID: 8327655
[TBL] [Abstract][Full Text] [Related]
13. Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup.
Coltman CA; Dixon DO
Cancer Treat Rep; 1982 Apr; 66(4):1023-33. PubMed ID: 7074630
[TBL] [Abstract][Full Text] [Related]
14. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
16. Second neoplasms following radiotherapy or chemotherapy for cancer.
Penn I
Am J Clin Oncol; 1982 Feb; 5(1):83-96. PubMed ID: 7081142
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for second malignant neoplasms: report from the Late Effects Study Group.
Meadows AT
Bull Cancer; 1988; 75(1):125-30. PubMed ID: 3359054
[TBL] [Abstract][Full Text] [Related]
18. A case-control study of leukaemia as a second primary malignancy following ovarian and breast neoplasms.
Mehnert WH; Haas JF; Kittelmann B; Staneczek W; Möhner M; Kaldor JM; Day NE
IARC Sci Publ; 1986; (78):203-21. PubMed ID: 3583391
[TBL] [Abstract][Full Text] [Related]
19. Cancer and secondary leukemia.
Rosner F
Bull Cancer; 1983; 70(1):55-60. PubMed ID: 6573207
[TBL] [Abstract][Full Text] [Related]
20. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
